Pfizer & Bristol-Myers See Positive Eliquis Test Results and 2 More Heavily Traded Stocks To Follow

Pfizer (NYSE:PFE): Closing price $27.64

Pfizer and partner Bristol-Myers Squibb Co. recently presented encouraging data concerning their drug Eliquis (apixaban) from a phase III evaluation AMPLIFY. The randomized, double-blind, multicenter six-month study examined Eliquis as a monotherapy compared to the standard of care of Sanofi’s Lovenox (enoxaparin) and warfarin in patients suffering with acute venous thromboembolism, which includes symptomatic deep vein thrombosis and/or pulmonary embolism. Data from the study showed the non-inferiority of Eliquis to the current standard of care in lowering of the composite endpoint of recurrent symptomatic VTE or death linked with VTE.

pfe

Bank of America Corp. (NYSE:BAC): Closing price $12.82

The Delaware Supreme Court is looking at whether former shareholders of Countrywide Financial Corp. can pursue a lawsuit filed prior to the company’s acquisition by Bank of America in 2008. The Delaware justices have been requested by a federal appeals court to clarify whether former Countrywide shareholders may continue a federal lawsuit filed in California through a “fraud exception” in Delaware law. Previously, judges in Delaware and California decided the buyout eliminated the shareholders’ standing through which to pursue their derivative claims.

bac

Cole Real Estate Investments (NYSE:COLE): Closing price $11.58

Cole announced the acquisition of three Class A office properties by the Cole Corporate Income Trust at a price of $160.8 million. The properties are located in Texas and Massachusetts, and include a multi-building Allstate corporate campus, corporate headquarters for Men’s Wearhouse, and a newly built office building that houses a multi-specialty medical practice operated by Harvard Vanguard Medical Associates. The income trust invests mostly in strategic single-tenant, income-generating necessity corporate properties leased to creditworthy tenants through long-term net leases.

cole

Investing Insights: Will US Airways Climb Higher?